Form 4: Kodiak Sciences CFO Reports Routine Stock Transactions Following RSU Vesting

Kodiak Sciences Inc.'s Executive Vice President and Chief Financial Officer, John A. Borgeson, reported the vesting of restricted stock units and a subsequent 'sell to cover' transaction for tax obligations.

Summary

• John A. Borgeson, Executive Vice President and Chief Financial Officer of Kodiak Sciences Inc. (KOD), reported transactions on June 15 and June 17, 2025, as detailed in a Form 4 filing.
• On June 15, 2025, 1,875 Restricted Stock Units (RSUs) vested. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
• These RSUs are part of a grant that vests one-fourth (1/4th) on each of the first four anniversaries of June 15, 2021, subject to Borgeson's status as a Service Provider.
• On June 17, 2025, Borgeson sold 723 shares of common stock at a price of $3.651 per share.
• This sale was explicitly a 'sell to cover' transaction, required to satisfy tax withholding obligations in connection with the RSU vesting, and was not a discretionary trade.
• Following these reported transactions, John A. Borgeson beneficially owns 183,316 shares of Kodiak Sciences Inc. common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the vesting of restricted stock units and a non-discretionary 'sell to cover' sale for tax purposes. This type of transaction is generally neutral as it does not reflect a change in management's confidence in the company.

Positives

• The sale of shares by the Reporting Person was a non-discretionary 'sell to cover' transaction, solely for the purpose of satisfying tax withholding obligations related to RSU vesting, rather than a discretionary sale that might indicate a lack of confidence in the company.

Future Outlook

NA

Management Comments

• "The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs on June 15, 2025. The sale satisfies the tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person."

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, common across publicly traded companies when executive compensation includes equity awards like Restricted Stock Units (RSUs) that vest over time. The 'sell to cover' mechanism is a standard practice for managing tax liabilities associated with such vesting events.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a routine, non-discretionary sale for tax purposes related to executive compensation, not indicative of a change in company fundamentals or management's outlook.

Key Dates

Keywords

Kodiak Sciences, KOD, John A. Borgeson, SEC Form 4, insider trading, restricted stock units, RSU vesting, sell to cover, tax withholding, beneficial ownership, financial officer